Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
Stopped early · Phase 2
Conditions studied: Liver Cancer, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Radiofrequency ablation is a procedure that heats tumors to several degrees above body temperature and may kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiofrequency ablation in treating patients who have unresectable primary or metastatic liver cancer.
Key facts
- Study ID
- NCT00019604
- Run by
- National Institutes of Health Clinical Center (CC)
- People needed
- 44
- Starts
- 1998-08-01
- Expected to finish
- 2009-01-01
- Last updated by the study team
- 2017-02-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.